Disease/Infection News

RSS

Epiphany Biosciences announces results from its valomaciclovir Phase 2b trial for shingles

Epiphany Biosciences announced results from its Phase 2b dose-ranging study of EPB-348 (valomaciclovir) in patients with shingles (herpes zoster) infection. The study's primary endpoint was non-inferiority of once-daily valomaciclovir compared to thrice-daily valacyclovir in terms of time to complete crusting of the shingles rash.

18 Nov 2009

Sinovac Biotech receives a revised production license for its Panflu.1 vaccine

Sinovac Biotech Ltd., a leading developer and provider of vaccines in China, announced today that it received a revised production license from State Food and Drug Administration for Panflu.1, the Company's H1N1 vaccine. The population has been expanded to include people over 60 years old. The shelf life for PANFLU.1 was extended to one year from six months.

18 Nov 2009

SynCon Chikungunya virus DNA vaccine induces protective neutralizing antibody responses in animal model

Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, announced today that the company's SynCon™ Chikungunya virus DNA vaccine induced protective neutralizing antibody responses in a preclinical non-human primate model.

18 Nov 2009

VirWall KBS-1 keyboard sanitizer eradicates bacteria and viruses on computer keyboards

Engineer/pilot/attorney Jon Roberts, PhD, has dozens of inventions to his credit. They include technology that thwarts piracy in movie theatres, gadgets that track important items inadvertently left behind, devices to enhance airport security and even an electronic matchmaker that alerts two nearby individuals with similar interests that they have, indeed, found their match.

18 Nov 2009

Loyola researcher says rapid influenza diagnostic tests can present significant risk to public health

Rapid influenza diagnostic tests used in doctors' offices, hospitals and medical laboratories to detect H1N1 are virtually useless and could pose a significant danger to public health, according to a Loyola University Medical Center researcher.

18 Nov 2009

Chembio Diagnostics to present possibilities of OTC home-use HIV test kits at the FDA meeting

Chembio Diagnostics, Inc., a company that develops, manufactures, licenses, and markets proprietary rapid diagnostic tests, announced today that it will present at a meeting of the Blood Products Advisory Committee ("BPAC") of the U.S. Food and Drug Administration ("FDA") in Bethesda, Maryland, on the afternoon of November 17, 2009.

18 Nov 2009

Accurate diagnostic tests required to fight against major infectious disease

A rapid and accurate diagnosis is the first step towards treatment in the fight against infectious disease. However, a team headed by Dr. Madhukar Pai at the Research Institute of the McGill University Health Centre (RI-MUHC) and McGill University in collaboration with researchers at the TDR* and the WHO*, has highlighted the poor quality of published studies that evaluate the accuracy of diagnostic tests for 3 major killer infectious diseases (TB, HIV/AIDS and malaria).

18 Nov 2009

Regulatory agencies offer marketing approval for new products to treat neglected diseases

New products to treat neglected diseases have received marketing approval from regulatory agencies at a steadily increasing rate in recent years as R&D funding for those diseases has increased, according to a recently completed study by the Tufts Center for the Study of Drug Development.

18 Nov 2009

Quest Diagnostics' Simplexa Influenza A H1N1 (2009) test receives CE mark

Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, today announced that the Simplexa Influenza A H1N1 (2009) test developed by its Focus Diagnostics business has been CE marked and is now available as a test kit for distribution to approximately 35 countries in Europe.

From Quest Diagnostics 18 Nov 2009

ED clinicians utilize WEBeMARS to report the progress of the H1N1 flu pandemic

EDIMS LLC, a leading provider of interoperable emergency department (ED) information management systems for hospitals, announced today that 22 of its client EDs in New York and New Jersey are reporting daily on the progress of the H1N1 flu pandemic to their state health departments.

18 Nov 2009

Previous flu infections can reduce the severity of H1N1

Researchers at the La Jolla Institute for Allergy & Immunology have found that previous influenza infections may provide at least some level of immunity to the H1N1 "swine" flu. "The question we asked was, "Is the swine flu more like the seasonal flu or like a totally new strain of influenza where there would be no immunity?," said Alessandro Sette, Ph.D., an internationally recognized vaccine expert and director of the La Jolla Institute's Center for Infectious Disease.

18 Nov 2009

Cinergy Health creates a guide for the prevention and treatment of H1N1

Cinergy Health, a nationwide provider of guaranteed issue health insurance benefit programs, has created a guide for consumers concerned about the H1N1 virus, which has already killed more than 4,000 Americans.

18 Nov 2009

Tips on how to prevent household members from getting sick during flu season

someone at home who has H1N1 (swine) flu, it is important for you to prevent other people in the house from getting sick, according to Gary Kalkut, MD, MPH, Senior Vice-President, Chief Medical Officer of Montefiore Medical Center.

18 Nov 2009

Global Alliance for Chronic Diseases announces targets

The Global Alliance for Chronic Diseases (GACD) on Monday outlined plans "to invest tens of millions of dollars in heart and lung disease studies in a battle against a global epidemic of chronic disease," over five years, Reuters reports.

17 Nov 2009

China, WHO to collaborate on flu research center

Chinese and WHO officials last week agreed to open a flu research center in Beijing, Bloomberg reports. "The new collaborating center for reference and research on influenza will join a network of WHO-affiliated labs in Atlanta, London, Tokyo and Melbourne that monitor flu strains and make recommendations on vaccines to fight the virus," the news service writes

17 Nov 2009

KHN column: Is fear of flu shifting the goal posts?

"If any public health message has alarmed Americans in recent weeks, it is the repeated claim in the media that healthy young people are dying of 2009 H1N1, or swine flu. ... The response has been predictable: frantic parents clogging waiting rooms in pediatricians' offices, lining up for hours to get their kids vaccinated, and rushing to fill prescriptions for anti-viral drugs before the local pharmacy runs out" (11/17).

17 Nov 2009

AIDS advocates ask White House to send money south

WLBT: "The White House Office of National AIDS Policy chose Jackson [Mississipppi] to host an HIV/AIDS town hall meeting Monday night. The community discussion allowed Mississippians to give feedback that will be included in a national strategy to end the HIV/AIDS epidemic. ... Many asked for sex and STD education in the schools, more doctors and transportation funding in rural areas and health insurance" (Anderson, 11/17).

17 Nov 2009

Bavarian Nordic awarded a new contract for developing a freeze-dried version of its IMVAMUNE smallpox vaccine

Bavarian Nordic A/S announced today that BARDA (Biomedical Advanced Research and Development Authority) has awarded a new contract to Bavarian Nordic for the development of a freeze-dried version of its IMVAMUNE(R) smallpox vaccine with a total prospective value of USD 40 million.

17 Nov 2009

Anacor Pharmaceuticals commences patient dosing in AN3365 Phase I clinical study

Anacor Pharmaceuticals today announced that it has dosed the first patient in a Phase I clinical study for AN3365, a novel boron-based, small-molecule drug candidate in development for the treatment of hospital infections caused by Gram-negative bacteria. The study will evaluate the safety, tolerability and pharmacokinetics of AN3365 in healthy volunteers.

17 Nov 2009

Go Travel Insurance urge gap year travellers to take out proper cover for swine flu

As swine flu threatens to make a resurgence, Go Travel Insurance have reinforced the need for gap year students to take out proper cover before they embark on their trip.

17 Nov 2009

Disease/Infection News

Epiphany Biosciences announces results from its valomaciclovir Phase 2b trial for shingles

Sinovac Biotech receives a revised production license for its Panflu.1 vaccine

SynCon Chikungunya virus DNA vaccine induces protective neutralizing antibody responses in animal model

VirWall KBS-1 keyboard sanitizer eradicates bacteria and viruses on computer keyboards

Loyola researcher says rapid influenza diagnostic tests can present significant risk to public health

Chembio Diagnostics to present possibilities of OTC home-use HIV test kits at the FDA meeting

Accurate diagnostic tests required to fight against major infectious disease

Regulatory agencies offer marketing approval for new products to treat neglected diseases

Quest Diagnostics' Simplexa Influenza A H1N1 (2009) test receives CE mark

ED clinicians utilize WEBeMARS to report the progress of the H1N1 flu pandemic

Previous flu infections can reduce the severity of H1N1

Cinergy Health creates a guide for the prevention and treatment of H1N1

Tips on how to prevent household members from getting sick during flu season

Global Alliance for Chronic Diseases announces targets

China, WHO to collaborate on flu research center

KHN column: Is fear of flu shifting the goal posts?

AIDS advocates ask White House to send money south

Bavarian Nordic awarded a new contract for developing a freeze-dried version of its IMVAMUNE smallpox vaccine

Anacor Pharmaceuticals commences patient dosing in AN3365 Phase I clinical study

Go Travel Insurance urge gap year travellers to take out proper cover for swine flu

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News